Copertina

Adverse events in rheumatoid arthritis patients under antimalarial treatment-Is there cardiovascular compromise?

Introduction: The antimalarials chloroquine and hydroxychloroquine have been used for several decades in treating malaria and some autoimmune diseases-mainly rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)-with excellent efficacy and safety. Due to the massive use of antimalarials w...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Pedro Santos-Moreno (Autore), Linda Ibatá (Autore), Susan Martínez (Autore), Gabriel-Santiago Rod (Autore), Laura Villarreal (Autore), Pedro Rodríguez (Autore), Wilberto Rivero (Autore), Fernando Rodríguez-Florido (Autore), Adriana Rojas-Villarraga (Autore)
Natura:	Libro
Pubblicazione:	Frontiers Media S.A., 2023-01-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Conflict between efficacy and economy in rheumatoid arthritis treatment: Iguratimod is found at a compromise
di: Masao Tanaka
Pubblicazione: (2021)

Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting
di: Mayara Costa de Camargo, et al.
Pubblicazione: (2019)

Oral events related to low-dose methotrexate in rheumatoid arthritis patients
di: Carlos Henrique Silva Pedrazas, et al.
Pubblicazione: (2010)

Are gene polymorphisms related to adverse events of methotrexate in patients with rheumatoid arthritis? A retrospective cohort study based on an updated meta-analysis
di: Jing Huang, et al.
Pubblicazione: (2020)

Potential Adverse Events Reported With the Janus Kinase Inhibitors Approved for the Treatment of Rheumatoid Arthritis Using Spontaneous Reports and Online Patient Reviews
di: Yun-Kyoung Song, et al.
Pubblicazione: (2022)

Liposomal Nanosystems in Rheumatoid Arthritis
di: Margarida Ferreira-Silva, et al.
Pubblicazione: (2021)

Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients
di: Xiao-Na Ma, et al.
Pubblicazione: (2024)

Cardiotoxicity in Biological Agent-Targeted Therapy for Rheumatoid Arthritis: ADR Signal Mining and Analysis of Food and Drug Administration Adverse Event Reporting System Database
di: Xiaoyan Tang, et al.
Pubblicazione: (2021)

Adiponectin and Atherosclerosis in Rheumatoid Arthritis
di: Patrick H. Dessein, et al.
Pubblicazione: (2014)

Genetic Markers of Cardiovascular Disease in Rheumatoid Arthritis
di: Luis Rodríguez-Rodríguez, et al.
Pubblicazione: (2012)

Study of Clinical and Epidemiological Factors in Patients Diagnosed with Rheumatoid Arthritis
di: Rolando Rodríguez Puga, et al.
Pubblicazione: (2023)

Rheumatoid Arthritis
Pubblicazione: (2022)

Rheumatoid arthritis
di: Yoshiya Tanaka
Pubblicazione: (2020)

Maxillofacial manifestations in patients with rheumatoid arthritis
di: Otto Alemán Miranda, et al.
Pubblicazione: (2019)

Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting system
di: Takeshi Honma, et al.
Pubblicazione: (2024)

Rheumatoid Arthritis Treatment
Pubblicazione: (2012)

Mitochondrial Dysfunction and Oxidative Stress in Rheumatoid Arthritis
di: María José López-Armada, et al.
Pubblicazione: (2022)

Lepromatous leprosy simulating rheumatoid arthritis - Report of a neglected disease
di: Tatiana Cristina Pedro Cordeiro de Andrade, et al.
Pubblicazione: (2017)

Skin in rheumatoid arthritis and seronegative arthritis
di: Pragathi Sankineni, et al.
Pubblicazione: (2019)

Rehabilitation in rheumatoid arthritis
di: Anna Golus, et al.
Pubblicazione: (2018)

Rehabilitation in rheumatoid arthritis
di: Anna Golus, et al.
Pubblicazione: (2018)

Early rheumatoid arthritis
di: P. Sarzi-Puttini, et al.
Pubblicazione: (2011)

Rheumatoid arthritis and atherosclerosis
di: B. Seriolo, et al.
Pubblicazione: (2003)

Leishmaniasis in rheumatoid arthritis
di: M. Cutolo, et al.
Pubblicazione: (2011)

Biomarkers in Rheumatoid Arthritis
di: Vincent Goëb, et al.
Pubblicazione: (2014)

Atherosclerosis in Rheumatoid Arthritis
di: Miguel A. González-Gay, et al.
Pubblicazione: (2012)

Rheumatoid arthritis and adverse pregnancy outcomes: a bidirectional two-sample mendelian randomization study
di: Tongmin Chang, et al.
Pubblicazione: (2024)

Evaluation of Ovarian Reserve in Women With Rheumatoid Arthritis
di: Sara Patricia Peña-Lizola, et al.
Pubblicazione: (2021)

Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis
di: Francisco C. Ceballos, et al.
Pubblicazione: (2023)

On Compromise
di: Morley, John, 1838-1923

Compromises
di: Repplier, Agnes, 1855-1950

Rheumatoid Arthritis Etiology, Consequences and Co-Morbidities
Pubblicazione: (2012)

Kunxian Capsule for Rheumatoid Arthritis: Inhibition of Inflammatory Network and Reducing Adverse Reactions Through Drug Matching
di: Yujun Tang, et al.
Pubblicazione: (2020)

Cardiovascular adverse event reporting in psoriasis and psoriatic arthritis biological therapy clinical trials
di: Sreejan Saha, BA, et al.
Pubblicazione: (2024)

Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis
di: Tarkiainen M, et al.
Pubblicazione: (2008)

Nurses adverse events report adding safety to pediatric nursing
di: Joana Isabel Cordeiro e Carvalho, et al.
Pubblicazione: (2023)

Association Between the Extent of Periodontal Inflammation and the Severity of Rheumatoid Arthritis in Japanese Patients With Rheumatoid Arthritis
di: Hiroko Hashimoto, et al.
Pubblicazione: (2021)

Diagnostics and physiotherapy in rheumatoid arthritis
di: Aleksandra Strońska, et al.
Pubblicazione: (2021)

Treatment of juvenile rheumatoid arthritis
di: Kwang Nam Kim
Pubblicazione: (2010)

The physiotherapist and juvenile rheumatoid arthritis
di: Joan Baldwin
Pubblicazione: (1972)